366 results
DEFA14A
IMGN
Immunogen, Inc.
29 Jan 24
Additional proxy soliciting materials
5:01pm
may not be able to obtain adequate price and reimbursement for any approved products, including the potential for delays or additional difficulties
8-K
IMGN
Immunogen, Inc.
29 Jan 24
Other Events
5:00pm
with regulatory authorities; the risk that ImmunoGen may not be able to obtain adequate price and reimbursement for any approved products, including
DEFA14A
IMGN
Immunogen, Inc.
24 Jan 24
Additional proxy soliciting materials
4:57pm
of anticipated interactions with regulatory authorities; the risk that ImmunoGen may not be able to obtain adequate price and reimbursement for any approved
8-K
IMGN
Immunogen, Inc.
24 Jan 24
Other Events
4:55pm
adequate price and reimbursement for any approved products, including the potential for delays or additional difficulties for ELAHERE in light of the FDA
DEFA14A
IMGN
Immunogen, Inc.
8 Jan 24
Additional proxy soliciting materials
4:12pm
and outcome of anticipated interactions with regulatory authorities; the risk that ImmunoGen may not be able to obtain adequate price and reimbursement
8-K
ccz yeo6ps8f9fkklcp
8 Jan 24
Other Events
4:11pm
DEFM14A
5x1i515h k17wx
2 Jan 24
Proxy related to merger
4:26pm
PREM14A
3t7gty0 xvongc
21 Dec 23
Preliminary proxy related to merger
4:52pm
DEFA14A
85j5qb3vdo8b9h8 4h
21 Dec 23
Additional proxy soliciting materials
3:54pm
DEFA14A
eg4ina7
30 Nov 23
Additional proxy soliciting materials
4:08pm
DEFA14A
EX-2.1
68wa1a7spwqp
30 Nov 23
Additional proxy soliciting materials
4:07pm
8-K
EX-2.1
nicww5n
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
8-K
EX-99.1
r85k 5hid
2 Nov 23
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
6:35am
8-K
EX-99.1
z3zjrxo rcw3ds
18 Sep 23
ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer
6:35am
8-K
EX-99.1
zh4mn g23f4so84rk
31 Jul 23
ImmunoGen Reports Recent Progress and Second Quarter 2023 Financial Results
6:40am
8-K
EX-3.1
qidau9d
16 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:15pm